According to the report " Preclinical In-vivo Imaging Market ", published by Market Data Forecast, the global market is projected to reach USD 1.0 Billion by 2021, at a CAGR of 6.15% from 2016 to 2021.

For full report refer to http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Preclinical in-vivo imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes.

Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/request-sample

Development of technologically advanced hybrid preclinical imaging systems and growing acceptance of preclinical imaging as a legitimate drug development tool are the factors that are driving the market growth globally. Growing number of CROs in emerging markets is attracting companies to invest in those region.

For customized report refer to http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/customize-report

Global market for Preclinical in-vivo imaging is segmented based on Type and Product into further sub-segments as follows:

1) By Modality
• Optical imaging
a) Bioluminescence/fluorescence imaging systems
b) Standalone fluorescence imaging systems
c) Optical + X-ray/optical + CT imaging systems

• Nuclear imaging
a) Micro-PET systems (standalone PET, PET/CT, and PET/MRI)
b) Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)
c) Tri-modality (PET/SPECT/CT) imaging systems

• Micro-MRI
• Micro-CT
• Micro-ultrasound
• Photoacoustic
• Magnetic particle imaging systems

2) By Reagents
• Optical imaging reagents
a) Bioluminescent reagents
b) Fluorescent imaging reagents

• Nuclear imaging reagents
a) Preclinical PET tracers
b) Preclinical SPECT probes

• MRI contrast agents
• Ultrasound contrast agents
• CT contrast agents

3) By Geographically
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle-East and Africa

Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/inquire

Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the global preclinical imaging systems market.

Buy now https://www.marketdataforecast.com/cart/buy-now/global-preclinical-in-vivo-imaging-market-582

About Market Data Forecast:

Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact Us:

Market Data Forecast, Inc.
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
[email protected]